Why the study?
Do implantable cardioverter-defibrillators prevent sudden death in high-risk patients with hypertrophic cardiomyopathy?
Population
128 patients with hypertrophic cardiomyopathy deemed to be at high risk of sudden death, age 8 to 82 years…
Design
Cohort
Follow-up
average 3.1 years
Loading...
Appropriate activations support ICD role in high-risk HCM; leaves open randomized confirmation of sudden-death prevention.
Do implantable cardioverter-defibrillators prevent sudden death in high-risk patients with hypertrophic cardiomyopathy?
Implantable cardioverter-defibrillators are highly effective in terminating life-threatening ventricular arrhythmias in high-risk patients with hypertrophic cardiomyopathy, supporting their use for both primary and secondary prevention.
A 2001 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: